[go: up one dir, main page]

Ramirez Garcia Luna, 2020 - Google Patents

The interaction between the immune and skeletal systems during bone repair: the role of mast cells

Ramirez Garcia Luna, 2020

View PDF
Document ID
11253258223344723670
Author
Ramirez Garcia Luna J
Publication year

External Links

Snippet

OBJECTIVE I: Quantify bone repair at timed intervals in Cpa3 Cre/+ and WT mice with surgically induced defects that model human femoral fractures...................................................... ................... 18 OBJECTIVE II: Identify markers of inflammatory and vascular cell function to …
Continue reading at escholarship.mcgill.ca (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix

Similar Documents

Publication Publication Date Title
Ortinau et al. Identification of functionally distinct Mx1+ αSMA+ periosteal skeletal stem cells
Matsuura et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice
Yu et al. Stromal cell‐derived factor‐1 (SDF‐1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase‐9 (MMP‐9) activity, and collagen transmigration
US9962408B2 (en) Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
Tang et al. Transmural inflammation by interferon‐γ‐producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms
Ramirez-GarciaLuna et al. Defective bone repair in mast cell-deficient Cpa3Cre/+ mice
Anitua et al. Platelet rich plasma in orthopaedics and sports medicine
US20240158488A1 (en) Methods of restoring functional capacity and lineage composition of an aging blood and vascular system
Banyatworakul et al. Responses of canine periodontal ligament cells to bubaline blood derived platelet rich fibrin in vitro
Xiang et al. Beyond resorption: osteoclasts as drivers of bone formation
AU2012239874A1 (en) Autologous human adult pluripotent Very Small Embryonic-Like (hVSEL) Stem Cell regeneration of bone and cartilage
US10426740B1 (en) Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
Ramirez Garcia Luna The interaction between the immune and skeletal systems during bone repair: the role of mast cells
Waletzko-Hellwig et al. In-vitro analysis of resorption processes following high hydrostatic pressure treatment of human trabecular bone
Ghali The role of interleukin-33 (IL-33) administration in cardiac function post-myocardial infarction
Torre-Pérez et al. Migration and differentiation of human umbilical cord stem cells after heart injury in chicken embryos
Johnson Cadherin-11 in Cardiovascular Mechanobiology: Altered Immune Response and Endothelial Contractility
Weinzierl Strategies for increasing tissue survival in critically perfused musculocutaneous flaps
Lokman Imaging the injured beating heart intravitally and the vasculoprotection afforded by haematopoietic stem cells in myocardial ischaemia/reperfusion injury
Liebig Culture-expanded articular chondrocytes: a potential cellular therapeutic for osteoarthritis with MSC-like properties
WO2025064116A1 (en) Compositions and methods for the treatment of fibrotic conditions and cancer
EP2552463B1 (en) Proangiogenic compositions, method for preparing them, and uses thereof
Rizzo Determinants of macrophage and neutrophil heterogeneity in cardiac repair after myocardial infarction
Oghazian Material-Mediated Tissue Induction; Geometrical, Surgical & Material Parameters
Jin et al. Effect of endolysin XZ. 700 on monocyte differentiation into osteoclasts and foreign body giant cells